183 related articles for article (PubMed ID: 26140605)
1. TPO-Induced Metabolic Reprogramming Drives Liver Metastasis of Colorectal Cancer CD110+ Tumor-Initiating Cells.
Wu Z; Wei D; Gao W; Xu Y; Hu Z; Ma Z; Gao C; Zhu X; Li Q
Cell Stem Cell; 2015 Jul; 17(1):47-59. PubMed ID: 26140605
[TBL] [Abstract][Full Text] [Related]
2. Isolation and phenotypic characterization of colorectal cancer stem cells with organ-specific metastatic potential.
Gao W; Chen L; Ma Z; Du Z; Zhao Z; Hu Z; Li Q
Gastroenterology; 2013 Sep; 145(3):636-46.e5. PubMed ID: 23747337
[TBL] [Abstract][Full Text] [Related]
3. CD110 promotes pancreatic cancer progression and its expression is correlated with poor prognosis.
Yan Z; Ohuchida K; Zheng B; Okumura T; Takesue S; Nakayama H; Iwamoto C; Shindo K; Moriyama T; Nakata K; Miyasaka Y; Ohtsuka T; Mizumoto K; Oda Y; Hashizume M; Nakamura M
J Cancer Res Clin Oncol; 2019 May; 145(5):1147-1164. PubMed ID: 30770989
[TBL] [Abstract][Full Text] [Related]
4. Thrombopoietin alone or in the presence of stem cell factor supports the growth of KIT(CD117)low/ MPL(CD110)+ human mast cells from hematopoietic progenitor cells.
Kirshenbaum AS; Akin C; Goff JP; Metcalfe DD
Exp Hematol; 2005 Apr; 33(4):413-21. PubMed ID: 15781331
[TBL] [Abstract][Full Text] [Related]
5. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis.
Itatani Y; Kawada K; Fujishita T; Kakizaki F; Hirai H; Matsumoto T; Iwamoto M; Inamoto S; Hatano E; Hasegawa S; Maekawa T; Uemoto S; Sakai Y; Taketo MM
Gastroenterology; 2013 Nov; 145(5):1064-1075.e11. PubMed ID: 23891973
[TBL] [Abstract][Full Text] [Related]
6. PKLR promotes colorectal cancer liver colonization through induction of glutathione synthesis.
Nguyen A; Loo JM; Mital R; Weinberg EM; Man FY; Zeng Z; Paty PB; Saltz L; Janjigian YY; de Stanchina E; Tavazoie SF
J Clin Invest; 2016 Feb; 126(2):681-94. PubMed ID: 26784545
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of an alternative splice variant of Mpl with a high affinity for TPO and its activation of ERK1/2 signaling.
Wang Q; Sun R; Wu L; Huang J; Wang P; Yuan H; Qiu F; Xu X; Wu D; Yu Y; Liu X; Zhang Q
Int J Biochem Cell Biol; 2013 Dec; 45(12):2852-63. PubMed ID: 24144576
[TBL] [Abstract][Full Text] [Related]
8. Thrombopoietin limits IL-6 release but fails to attenuate liver injury in two hepatic stress models.
Eipel C; Hardenberg Jv; Negendank S; Abshagen K; Vollmar B
Eur J Gastroenterol Hepatol; 2009 Aug; 21(8):923-31. PubMed ID: 19417678
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase C and c-myc gene activation pathways in thrombopoietin signal transduction.
Kunitama M; Shimizu R; Yamada M; Kato T; Miyazaki H; Okada K; Miura Y; Komatsu N
Biochem Biophys Res Commun; 1997 Feb; 231(2):290-4. PubMed ID: 9070265
[TBL] [Abstract][Full Text] [Related]
10. STAT3 NH2-terminal acetylation is activated by the hepatic acute-phase response and required for IL-6 induction of angiotensinogen.
Ray S; Boldogh I; Brasier AR
Gastroenterology; 2005 Nov; 129(5):1616-32. PubMed ID: 16285960
[TBL] [Abstract][Full Text] [Related]
11. Thrombopoietin is a growth factor for rat hepatic progenitors.
Schmelzer E; Deiwick A; Bruns H; Fiegel HC; Bader A
Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):209-16. PubMed ID: 18301302
[TBL] [Abstract][Full Text] [Related]
12. Thrombopoietin stimulates migration and activates multiple signaling pathways in hepatoblastoma cells.
Romanelli RG; Petrai I; Robino G; Efsen E; Novo E; Bonacchi A; Pagliai G; Grossi A; Parola M; Navari N; Delogu W; Vizzutti F; Rombouts K; Gentilini P; Laffi G; Marra F
Am J Physiol Gastrointest Liver Physiol; 2006 Jan; 290(1):G120-8. PubMed ID: 16150872
[TBL] [Abstract][Full Text] [Related]
13. A novel role of thrombopoietin as a physiological modulator of coronary flow.
Ramella R; Gallo MP; Spatola T; Lupia E; Alloatti G
Regul Pept; 2011 Feb; 167(1):5-8. PubMed ID: 21237210
[TBL] [Abstract][Full Text] [Related]
14. The Mpl receptor expressed on endothelial cells does not contribute significantly to the regulation of circulating thrombopoietin levels.
Geddis AE; Fox NE; Kaushansky K
Exp Hematol; 2006 Jan; 34(1):82-6. PubMed ID: 16413394
[TBL] [Abstract][Full Text] [Related]
15. Expression of active thrombopoietin and identification of its key residues responsible for receptor binding.
Hou J; Zhan H
Cytokine; 1998 May; 10(5):319-30. PubMed ID: 9619369
[TBL] [Abstract][Full Text] [Related]
16. c-Kit is suppressed in human colon cancer tissue and contributes to L1-mediated metastasis.
Gavert N; Shvab A; Sheffer M; Ben-Shmuel A; Haase G; Bakos E; Domany E; Ben-Ze'ev A
Cancer Res; 2013 Sep; 73(18):5754-63. PubMed ID: 24008320
[TBL] [Abstract][Full Text] [Related]
17. Gene expression and transcriptional regulation of thrombopoietin.
Ogami K
Stem Cells; 1996; 14 Suppl 1():148-53. PubMed ID: 11012215
[TBL] [Abstract][Full Text] [Related]
18. The expression of thrombopoietin and its receptor during different physiological stages in the bovine ovary.
Sarkar M; Schilffarth S; Schams D; Meyer H; Berisha B
Reprod Domest Anim; 2011 Oct; 46(5):757-62. PubMed ID: 21198971
[TBL] [Abstract][Full Text] [Related]
19. The global histone modification pattern correlates with overall survival in metachronous liver metastasis of colorectal cancer.
Tamagawa H; Oshima T; Shiozawa M; Morinaga S; Nakamura Y; Yoshihara M; Sakuma Y; Kameda Y; Akaike M; Masuda M; Imada T; Miyagi Y
Oncol Rep; 2012 Mar; 27(3):637-42. PubMed ID: 22076537
[TBL] [Abstract][Full Text] [Related]
20. Investigation of the roles of exosomes in colorectal cancer liver metastasis.
Wang X; Ding X; Nan L; Wang Y; Wang J; Yan Z; Zhang W; Sun J; Zhu W; Ni B; Dong S; Yu L
Oncol Rep; 2015 May; 33(5):2445-53. PubMed ID: 25760247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
